Riskpilot← Back to searchSign inGet full accessVendelsö Apotek AB
ABActiveOrg 5594204702Skomakarvägen 20Retail sale of pharmaceutical products · NACE 4773Est. 20231 employees
Revenue 2024
SEK 26,2M
+297% vs 2023
EBITDA margin
1.7%
+212% vs 2023
Equity ratio
2.6%
Financial strength
Net profit 2024
SEK 188K
+1385% vs 2023
| Revenue | SEK 26,2M | +297% |
| EBITDA | SEK 439K | +212% |
| Net profit | SEK 188K | +1385% |
| Total assets | SEK 8,9M | +44% |
| Equity | SEK 226K | +500% |
| Employees | 1 | — |
Legal name
Vendelsö Apotek AB
Org number
5594204702
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
1 februari 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva handel med receptbelagda-, receptfria-, medicintekniska- och handelsvaror för försäljning och distribution till konsumenter genom ett apotek och därmed förenlig verksamhet.
Address
Skomakarvägen 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 6 607 | 26 213 |
| Staff expenses | −2 055 | −0 |
| EBITDA | 141 | 439 |
| Depreciation & amort. | −121 | −209 |
| EBIT | 19 | 230 |
| Net financials | 1 | 6 |
| Profit before tax | 20 | 236 |
| Tax | −8 | −47 |
| Net profit | 13 | 188 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 6 168 | 8 851 |
| Equity | 38 | 226 |
| Long-term debt | 2 470 | 2 470 |
| Short-term debt | 3 660 | 6 155 |
| Total debt | 6 130 | 8 625 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20232024
Equity ratio
2.6%
This company
38.2%
Market median
-93% vs market
20232024
Return on equity
83.3%
This company
18.4%
Market median
+353% vs market
20232024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20232024
Asset turnover
2.96×
This company
1.12×
Market median
+164% vs market
20232024
Debt / equity
38.14×
This company
0.62×
Market median
-6052% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SS Audit | Audit | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2023 | |
| Former (4) | ||
| Board of Directors | 2023 – 2025 | |
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vendelsö Apotek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shan Shaho Kosari | Audit | 0 companies |
| Zahraa Amer Abdulmalek Dabdawb | Board of Directors | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Amel Jaffar Mahmoud | Board of Directors | 0 companies |
| Walid Kheder Antouan Katan | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |